BIO-Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

PC

Pullan Consulting at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

Pullan Consulting takes part in 1 session at BIO-Europe 2026 in Cologne. Its program centres on cancer drug investment, asking where investors, pharma and biotech are placing their bets on the next oncology winners. The discussion is shared with Debiopharm, Epitopea, SRTD Biotech and Women in Life Science Denmark.

OrganizationBIO-Europe 2026 Attendance
PC
Pullan Consulting
Panel
Mon Nov 9
15:00–15:45
The next oncology winners: Where investors, pharma and biotech are placing their bets
Which cancer treatments, from radioactive targeted drugs to newer immunotherapies, now draw investors, and what makes a cancer biotech worth funding.
with SRTD Biotech, Debiopharm, Women in Life Science Denmark +1 more

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Pullan Consulting

Tell us what you sell and we’ll find the people at Pullan Consulting most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction